肾动脉支架置入术与单纯药物治疗对动脉粥样硬化性肾动脉狭窄的有效性及对患者预后的影响对比  

Comparison of the Effectiveness of Renal Artery Stenting and Drug Therapy Alone on Atherosclerotic Renal Artery Stenosis and the Impact on the Prognosis of Patients

作　　者：付华鹏 张意 FU Hua-peng;ZHANG Yi(Department of Cardiovascular Medicine,People’s Hospital of Duchang County,Jiangxi Jiujiang 332600)

机构地区：[1]都昌县人民医院心血管内科,江西九江332600

出　　处：《中国医疗器械信息》2024年第11期142-144,共3页China Medical Device Information

摘　　要：目的:分析比较肾动脉支架置入术、单纯药物治疗对动脉粥样硬化性肾动脉狭窄(ARAS)患者的影响。方法:选取2020年6月~2023年6月本院收治的100例ARAS患者,随机分成两组,均50例。对照组行单纯药物治疗,观察组行肾动脉支架置入术,术后随访6个月。对比两组血压、血肌酐、不良心血管事件发生率。结果:治疗前后,两组收缩压、舒张压、血肌酐相当,无统计学差异(P>0.05);观察组不良心血管事件发生率低于对照组,有统计学差异(P<0.05)。结论:单纯药物治疗、肾动脉支架置入术均能够改善ARAS患者的血压与肾功能,而后者更能够降低不良心血管事件发生率,具有一定的应用价值。Objective:To analyze and compare the effects of renal artery stenting(PTRAS)and drug therapy alone on atherosclerotic renal artery stenosis(ARAS).Methods:100 ARAS patients admitted to our hospital from June 2020 to June 2023 were selected and randomly divided into two groups,each with 50 cases.The control group received simple drug treatment,while the observation group received PTRAS.The postoperative follow-up was 6 months.Compare the incidence of blood pressure,creatinine(Scr),and adverse cardiovascular events(MACE)between two groups.Results:Before and after treatment,the systolic blood pressure(SBP),diastolic blood pressure(DBP),and Scr were comparable between the two groups(P>0.05);The incidence of MACE in the observation group was lower than that in the control group(P<0.05).Conclusion:Both drug therapy alone and PTRAS can improve blood pressure and renal function in patients with ARAS,with the latter also reducing the incidence of Major Adverse Cardiovascular Events(MACE),which has significant practical value.

关 键 词：动脉粥样硬化性肾动脉狭窄 血压 血肌酐 不良心血管事件 肾功能 

分 类 号：R699.1[医药卫生—泌尿科学]